After more than a decade primarily propelled by medical education and primary care, India’s Ayush sector—encompassing Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy—is transitioning toward secondary and tertiary care. This next phase of expansion is increasingly being supported by broader insurance coverage and rising private sector investments in specialized hospitals.
Key Growth Indicators (Ministry Data)
-
Educational Expansion: Government data submitted in Parliament shows that undergraduate colleges offering Ayush courses grew sharply from 520 in 2013–14 to 921 in 2025–26.
-
Public Infrastructure Growth: Dedicated Ayush dispensaries scaled from 26,130 in 2013–14 to 37,804 in 2024–25.
-
Hospital Infrastructure: Specialized Ayush hospitals expanded at a more measured pace, moving from 3,605 to 3,885 over the same timeframe.
The Road Ahead: Evidence-Based Treatment
While financial backing, institutional investments, and wider health insurance integration are paving the way for advanced secondary and tertiary care facilities, industry experts emphasize that rigorous, evidence-based treatment protocols will remain critical to scaling mainstream acceptance and consumer trust.
